Article Text

Download PDFPDF
No differences in efficacy of atypical and typical antipsychotics in early psychosis, but side effects differ

Statistics from Altmetric.com

Footnotes

  • Source of funding The corresponding author received a fellowship from the National Institute of Health Research, UK.

Footnotes

  • Competing interests TSS has received consulting fees from Janssen. LFJ has received research funding from GSK and Novartis, and consulting fees from AstraZeneca.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.